Reaction

Incorrect Dosage Administered reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 4,846 reports · 86 co-occurring drugs

As of the last recalculation, Incorrect Dosage Administered appears in 4,846 FAERS reports alongside 86 co-occurring drug terms. The strongest observed disproportionality signal is APALUTAMIDE (PRR 24.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Apalutamide	65	24.1	24.2
Naproxen Sodium Tablet	278	23.8	23.9
Relugolix	126	23.5	23.7
Droxidopa	63	12.7	12.7
Polyethylene Glycol 3350	232	10.9	10.9
Naproxen Sodium	304	9.7	9.7
Clobetasol Propionate Ointment Usp, 0.05%	22	9.2	9.2
Clobetasol Propionate	22	9.2	9.2
Infliximab-Dyyb	54	8.0	8.0
Mometasone Furoate And Formoterol Fumarate Dihydrate	23	6.4	6.4
Loratadine Tablet	75	6.1	6.1
Acetaminophen, Aspirin (Nsaid) And Caffeine	23	5.8	5.8
Acetaminophen, Aspirin, And Caffeine	27	5.5	5.5
Somatropin	87	5.2	5.2
Vigabatrin	17	5.0	5.0
Loratadine And Pseudoephedrine Sulfate	9	4.9	4.9
Teduglutide	15	4.8	4.8
Diclofenac Sodium	162	4.7	4.8
Fluticasone Propionate And Salmeterol	42	4.4	4.4
Magnesium Hydroxide	13	4.2	4.2
Valacyclovir	40	4.1	4.1
Sulfasalazine	71	3.9	3.9
Fluticasone Propionate And Salmeterol Xinafoate	52	3.7	3.8
Atorvastatin Calcium, Film Coated	58	3.6	3.6
Loratadine	84	3.4	3.4
Leflunomide	78	3.2	3.2
Linaclotide	20	3.2	3.2
Atovaquone	6	3.2	3.2
Regorafenib	8	3.0	3.0
Insulin Lispro	92	2.9	2.9
Nirmatrelvir And Ritonavir	36	2.9	2.9
Mupirocin	9	2.9	2.9
Dabrafenib	14	2.9	2.9
Secukinumab	103	2.8	2.8
Nebivolol	10	2.7	2.7
Trametinib	15	2.7	2.7
Suvorexant	8	2.7	2.7
Valacyclovir Hydrochloride	43	2.6	2.6
Sitagliptin And Metformin Hydrochloride	13	2.6	2.6
Riociguat	19	2.5	2.5
Calcium, Magnesium, Potassium, And Sodium Oxybates	5	2.5	2.5
Carboxymethylcellulose Sodium	5	2.3	2.3
Armodafinil	11	2.2	2.2
Bimatoprost	15	2.2	2.2
Lisdexamfetamine Dimesylate	17	2.2	2.2
Levodopa	6	2.1	2.1
Lifitegrast	8	2.1	2.1
Umeclidinium Bromide And Vilanterol Trifenatate	8	2.1	2.1
Budesonide, Glycopyrrolate, And Formoterol Fumarate	5	2.1	2.1
Eltrombopag Olamine	11	2.1	2.1
Canakinumab	5	2.0	2.0
Fesoterodine Fumarate	5	2.0	2.0
Levonorgestrel	92	2.0	2.0
Voclosporin	4	2.0	2.0
Sacubitril And Valsartan	52	1.9	1.9
Aflibercept	14	1.9	1.9
Siponimod	4	1.9	1.9
Tofacitinib	82	1.9	1.9
Rivaroxaban	86	1.8	1.8
Dronedarone	4	1.7	1.7
Cannabidiol	9	1.7	1.7
Olaparib	8	1.6	1.6
Salicylic Acid	20	1.6	1.6
Brexpiprazole	6	1.6	1.6
Rucaparib	3	1.5	1.5
Romiplostim	5	1.4	1.4
Acalabrutinib	4	1.4	1.4
Eptinezumab-Jjmr	3	1.4	1.4
Fam-Trastuzumab Deruxtecan-Nxki	3	1.3	1.3
Ixekizumab	11	1.3	1.3
Trifluridine And Tipiracil	3	1.2	1.2
Lenvatinib	9	1.2	1.2
Isotretinoin	12	1.0	1.0
Abaloparatide	7	1.0	1.0
Abiraterone Acetate	9	0.9	0.9
Dupilumab	104	0.9	0.9
Glycerin, Lidocaine	3	0.9	0.9
Dulaglutide	19	0.9	0.9
Apremilast	30	0.9	0.9
Docosanol	3	0.9	0.9
Paliperidone Palmitate	6	0.8	0.8
Pirfenidone	7	0.7	0.7
Cinacalcet Hydrochloride	8	0.7	0.7
Esketamine Hydrochloride	3	0.7	0.7
Pimavanserin Tartrate	8	0.6	0.6
Tirzepatide	20	0.5	0.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.